-
KIIT School of Pharmacy Organizes Guest Lecture on “Concept and Best Practices of Pharmacovigilance and Materiovigilance Programme of India”
-
KIIT School of Pharmacy Organizes Guest Lecture on “Concept and Best Practices of Pharmacovigilance and Materiovigilance Programme of India”
-
KIIT School of Pharmacy Organizes Guest Lecture on “Concept and Best Practices of Pharmacovigilance and Materiovigilance Programme of India”
-
KIIT School of Pharmacy Organizes Guest Lecture on “Concept and Best Practices of Pharmacovigilance and Materiovigilance Programme of India”
KIIT School of Pharmacy, Bhubaneswar, organised an insightful lecture on May 5, 2025, on the topic “Concept and Best Practices of Pharmacovigilance and Materiovigilance Programme of India.” The session was delivered by Dr. V. Kalaiselvan, Senior Principal Scientific Officer, Indian Pharmacopoeia
The event was graced by Brig. Prof.(Dr.) Ambika Prasad Mohanty, Director, KIMS and AVM Prof. (Dr.) Rama Chandra Das, Dean and Principal, KIMS. The guest was introduced by Dr. Biswaranjan Behera, Principal, KIIT School of Pharmacy and was felicitated by the Director and Dean; Principal, KIMS.
Dr. Kalaiselvan comprehensively outlined the fundamentals of drug safety, rational use of medicines and the latest rules and regulations under the Indian Pharmacopoeia. He placed strong emphasis on the significant national initiatives of the Pharmacovigilance programme of India(PvPI) and the Materiovigilance Programme of India (MvPI) which are pivotal in ensuring the safety of medicines and medical devices in the country. These initiatives play a crucial role in enhancing patient safety and promoting the rational use of therapeutic products nationwide.
Overall, the guest lecture was highly informative, offering valuable perspectives on the Indian Pharmacopoeia Commission’s recent efforts to strengthen the country’s healthcare system. Considering the critical role of Pharmacy professionals in the assessment and reporting of adverse events associated with Drug and medical devices, Dr. Kalaiselvan provided deep insights into how their active participation can advance drug safety monitoring and improve healthcare outcomes. The lecture also shed light on career opportunities in Clinical Research Organisations (CROs) and regulatory affairs, followed by an engaging interactive session where students clarified doubts and explored future prospects. The programme concluded with a vote of thanks by the Principal, KIIT School of Pharmacy.